乙型肝炎病毒(HBV)是人类急慢性肝炎、肝硬化和肝细胞癌的主要病因。
Hepatitis B virus (HBV) is a major cause of acute and chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma in humans.
结论：这里我们鉴别了在等待肝移植的HCV -肝癌患者中，和肝细胞癌进展相关的基因。
CONCLUSIONS: Here, we have identified genes associated with HCC progression in HCV-HCC patients awaiting LT transplantation.
这一结果是令人鼓舞的，因为在最初治疗之后肝细胞癌反应的早期看法是必要的，以便改善预后和指导今后的治疗。
This result is encouraging because early knowledge of HCC response after initial therapy is essential to revise prognosis and guide future therapy.
研究肝细胞癌(HCC)组织中基质金属蛋白酶2 (MMP鄄2)和血管内皮生长因子(VEGF)蛋白的表达及其临床意义。
To investigate the expression of matrix metalloproteinase 2 (MMP-2) and vascular endothelial growth factor (VEGF) in hepatic cellular carcinoma (HCC) and its significance.
在中国和远东，超过80%的肝细胞癌患者有慢性乙肝病毒的感染。
In parts of China and the Far East, over 80% of HCC patients have chronic HBV infection.
目的研究血小板反应蛋白1（TSP 1）和血管内皮生长因子（VEGF）的平衡在肝细胞癌（HCC）新生血管生成中的作用。
Objective To study the role of the balance between thrombospondin-1 (TSP-1) and vascular endothelial growth factor (VEGF) in the neovascularization of hepatocellular carcinoma (HCC).
持续病毒学应答可以降低肝硬化和肝病并发症的发生，降低肝癌(肝细胞性癌)和死亡的发生率。
Sustained virologic response can result in decreased cirrhosis and complications of liver disease, decreased rates of liver cancer (hepatocellular carcinoma), and decreased mortality.
方法：采用SP免疫细胞化学方法，检测70例肝细胞癌组织中P 36的分布和表达。
Methods: SP immunocytochemical techniques were used to detect the distribution and expression of P36 in 70 cases of hepatocellular carcinoma.
目的探讨CD 44V6和VEGF在肝细胞癌(HCC)中的表达及其在临床预后中的价值。
Objective to investigate expression of CD44 V6 and VEGF in hepatocellular carcinoma (HCC) and its clinical prognostic significance.
结论门静脉受侵肝细胞癌患者的预后与肝癌分期、肿瘤的数目和治疗方法密切相关。
Conclusion the prognosis of HCC patients with portal vein invasion is closely related with patient's HCC stage, number of tumors and methods of therapy.
乙肝患者经历以下的疾病状态：病毒抑制、病毒血症期、血清转化、肝细胞癌、肝硬化和死亡。
Patients cycled between the following health states: viral suppression, ongoing viremia, seroconversion, hepatocellular carcinoma, cirrhosis and death.
方法：采用原位细胞凋亡、免疫组织化学及其双染色等技术，对70例肝细胞癌（HCC）和10例慢性肝炎的组织标本进行研究。
Methods: Expression of HCV antigens and apoptosis were demonstrated using IHC and in situ cell death detecting in samples from 70 HCC and 10 chronic hepatitis.
这个词的意思是“肝脏的炎症”，先前的研究者也指出，乙肝病毒和丙肝病毒是肝细胞癌的两个主要病因。
The word "hepatitis" means "inflammation of the liver," and previous research has shown HBV and HCV are major causes of liver cancer. Little is known about their roles in other cancers.
结论：肝细胞癌的磁共振动态增强曲线和对比增强率能够反映肿瘤微血管形成程度，从而有助于判断病人的预后。
Conclusion: The MR dynamic curves and contrast enhancement ratio may prove useful in estimating angiogenic activity and indicating prognosis in HCCs.
HBV感染可导致肝衰竭、肝硬化和原发性肝细胞癌。
Infection of HBV causes hepatic failure, cirrhosis and hepatocellular carcinoma (HCC).
您在胃肠病学杂志上发表了1篇关于肝细胞癌诊断和治疗的文章，在这篇文章中你推荐了一种HCC护理方法。
In your article Diagnosis And Treatment Of Hepato-cellular Carcinoma, in Gastroenterology, you presented a recommended-management approach for HCC.
方法应用免疫组织化学方法检测41例肝细胞肝癌及其癌旁组织中COX - 2和P -糖蛋白的表达情况。
Methods We detected the expressions of COX-2 and P-glucoprotein in the tissues inside and beside the tumor and normal tissues of 41 cases hepatocellular carcinoma in immunohistochemistry method.
肝细胞癌是最常见的恶性肿瘤之一，虽然其诊断和治疗有不少进展，但其预后仍较差，病死率较高。
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Despite great advances made in diagnosis and treatment of HCC, its prognosis is poor and the mortality rate remains high.
肝细胞癌(简称肝癌)是全球第五位的癌症和第三个最常见肿瘤相关死亡的原因。
Hepatocellular carcinoma (HCC) is the fifth most common carcinoma and the third leading cause of death by cancer in the world.
利用基于支持向量机模型的31P磁共振波谱数据对肝脏进行分类，区别肝细胞癌，肝硬化和正常的肝组织。
We use SVM model based on 31p MRS to distinguish three diagnostic types of hepatocellular carcinoma, hepatic cirrhosis and normal hepatic tissue.
肝细胞癌是较易被忽视的癌症之一。此系统的重要性和临床意义是什么？
Hepatocellular carcinoma is one of the more forgotten cancers and so what is the significance and clinical implications of this system?
其中肝细胞性肝癌77例(84.6%)，胆管癌9例(9.9%)，混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
由于缺乏预测进展和复发的肿瘤标志物那些有可能被治疗的更高阶段的肝细胞癌的患者被拒绝用肝移植疗法。
Potentially curable higher-stage HCC patients are denied LT due to the lack of cancer markers that predict progression and recurrence.
摘要：目的利用氢质子磁共振波谱分析肝细胞癌和胆管细胞癌代谢物变化。
ABSTRACT: Objective to investigate the value of in vivo proton magnetic resonance spectroscopy (1h MRS) in the assessment of hepatocellular carcinoma (HCC) and cholangiocarcinoma.
摘要：目的利用氢质子磁共振波谱分析肝细胞癌和胆管细胞癌代谢物变化。
ABSTRACT: Objective to investigate the value of in vivo proton magnetic resonance spectroscopy (1h MRS) in the assessment of hepatocellular carcinoma (HCC) and cholangiocarcinoma.
应用推荐